Last reviewed · How we verify
Naltrexone immediate release oral capsules — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Naltrexone immediate release oral capsules (Naltrexone immediate release oral capsules) — Scilex Pharmaceuticals, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Naltrexone immediate release oral capsules TARGET | Naltrexone immediate release oral capsules | Scilex Pharmaceuticals, Inc. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Naltrexone immediate release oral capsules CI watch — RSS
- Naltrexone immediate release oral capsules CI watch — Atom
- Naltrexone immediate release oral capsules CI watch — JSON
- Naltrexone immediate release oral capsules alone — RSS
Cite this brief
Drug Landscape (2026). Naltrexone immediate release oral capsules — Competitive Intelligence Brief. https://druglandscape.com/ci/naltrexone-immediate-release-oral-capsules. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab